IRCT20100228003449N27招募中2 期
Evaluating efficacy and safety of interferone ß-1b (IFN ß-1b) in the treatment of COVID-19
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Patients with highly suspected or confirmed COVID-19 who are candid for hospitalization and starting triple-drug combination.
排除标准
- •History of drug allergy
- •Pregnancy and lactation
- •Uncontrolled baseline diseases including neuropsychiatric disorders, diabetes, thyroid disorders, heart disease, baseline liver failure
研究者
相似试验
已完成
2 期
Interferon in treatment of COVID-19COVID-19 pneumonia.IRCT20100228003449N28Tehran University of Medical Sciences30
招募中
3 期
Investigating the efficacy and safety of Interferon Beta1a nasal spray in controlling the symptoms of patients with COVID-19COVID-19.Covid-19U07.1IRCT20080901001165N53Bagheiat-allah University of Medical Sciences100
招募中
不适用
Analysis of efficacy and safety of interferon-free therapy for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000018759Kyoto University Hospital50
招募中
3 期
Efficacy and safety of Interferon beta-1-a in mild to moderate COVID-19IRCT20120703010178N25Shahid Beheshti University of Medical Sciences100
招募中
不适用
Investigation of clinical efficacy and safety of intramuscular administration of autologous total IgG therapy in patients with chronic urticariaDiseases of the skin and subcutaneous tissueKCT0006814Ajou University Hospital24